Sangamo Therapeutics (SGMO)
(Real Time Quote from BATS)
$0.54 USD
+0.04 (7.83%)
Updated Apr 23, 2024 01:02 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.22 |
EPS Last Quarter | -0.34 |
Last EPS Surprise | -36.00% |
ABR | 1.75 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.54 |
Next Year | -0.27 |
EPS (TTM) | -0.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.51M | 11.34M | 46.34M | 93.95M |
# of Estimates | 3 | 3 | 4 | 4 |
High Estimate | 11.30M | 17.80M | 59.90M | 229.00M |
Low Estimate | 3.00M | 5.00M | 32.45M | 33.08M |
Year ago Sales | 157.96M | 6.84M | 176.23M | 46.34M |
Year over Year Growth Est. | -94.61% | 65.83% | -73.71% | 102.74% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.22 | -0.14 | -0.54 | -0.27 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | -0.26 | -0.13 | -0.38 | -0.20 |
High Estimate | -0.10 | -0.10 | -0.38 | 0.28 |
Low Estimate | -0.27 | -0.21 | -0.77 | -0.64 |
Year ago EPS | 0.12 | -0.37 | -0.59 | -0.54 |
Year over Year Growth Est. | -283.33% | 62.16% | 8.47% | 49.26% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 2 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.22 | -0.14 | -0.54 | -0.27 |
7 Days Ago | -0.22 | -0.14 | -0.54 | -0.27 |
30 Days Ago | -0.22 | -0.14 | -0.54 | -0.27 |
60 Days Ago | -0.10 | -0.07 | -0.48 | -0.43 |
90 Days Ago | -0.10 | -0.07 | -0.48 | -0.43 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.22 | -0.14 | -0.54 | -0.27 |
Zacks Consensus Estimate | -0.22 | -0.14 | -0.54 | -0.27 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.34 | -0.34 | -0.37 | 0.12 | NA |
Estimate | -0.25 | -0.33 | -0.35 | 0.14 | NA |
Difference | -0.09 | -0.01 | -0.02 | -0.02 | -0.04 |
Surprise | -36.00% | -3.03% | -5.71% | -14.29% | -14.76% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more